Gastrointestinal Drug Absorption: Is It Time to Consider Heterogeneity as Well as Homogeneity?

The current analysis of gastrointestinal absorption phenomena relies on the concept of homogeneity. However, drug dissolution, transit and uptake in the gastrointestinal tract are heterogeneous processes since they take place at interfaces of different phases under variable stirring conditions. Recent advances in physics and chemistry demonstrate that the geometry of the environment is of major importance for the treatment of heterogeneous processes. In this context, the heterogeneous character of in vivo drug dissolution, transit and uptake is discussed in terms of fractal concepts. Based on this analysis, drugs are classified in accordance with their gastrointestinal absorption characteristics into two broad categories i.e. homogeneous and heterogeneous. The former category includes drugs with satisfactory solubility and permeability which ensure the validity of the homogeneous hypothesis. Drugs with low solubility and permeability are termed heterogeneous since they traverse the entire gastrointestinal tract and therefore are more likely to exhibit heterogeneous dissolution, transit and uptake. The high variability of whole bowel transit and the unpredictability of conventional dissolution tests for heterogeneous drugs are interpreted on the basis of the fractal nature of these processes underin vivoconditions. The implications associated with the use of strict statistical criteria in bioequivalence studies for heterogeneous drugs are also pointed out.

[1]  D. Cutler,et al.  Numerical deconvolution by least squares: Use of prescribed input functions , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  I. Wilding,et al.  Colonic transit of different sized tablets in healthy subjects , 1993 .

[3]  D N Wheatley,et al.  Intracellular transport mechanisms: a critique of diffusion theory. , 1995, Journal of theoretical biology.

[4]  H. Stanley,et al.  Fractal growth viscous fingers: quantitative characterization of a fluid instability phenomenon , 1985, Nature.

[5]  N. Modi,et al.  Optimal extravascular dosing intervals , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  Gordon L. Amidon,et al.  Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.

[7]  Nobuo Aoyagi,et al.  Estimation of Agitation Intensity in the GI Tract in Humans and Dogs Based on in Vitro/in Vivo Correlation , 1995, Pharmaceutical Research.

[8]  D. Cutler Numerical deconvolution by least squares: Use of polynomials to represent the input function , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[9]  D. Wheatley Diffusion theory in biology: its validity and relevance , 1993 .

[10]  M. Shameem,et al.  Oral Solid Controlled Release Dosage Forms: Role of GI-Mechanical Destructive Forces and Colonic Release in Drug Absorption Under Fasted and Fed Conditions in Humans , 1995, Pharmaceutical Research.

[11]  S. Davis,et al.  Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .

[12]  Peter Veng-Pedersen,et al.  An algorithm and computer program for deconvolution in linear pharmacokinetics , 1980, Journal of Pharmacokinetics and Biopharmaceutics.

[13]  S. Gull,et al.  Maximum entropy and its application to the calculation of drug absorption rates , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[14]  L S Liebovitch,et al.  Fractal model of ion-channel kinetics. , 1987, Biochimica et biophysica acta.

[15]  G. Digenis,et al.  Gamma scintigraphy and neutron activation techniques in the in vivo assessment of orally administered dosage forms. , 1991, Critical reviews in therapeutic drug carrier systems.

[16]  Panos Macheras,et al.  A Fractal Approach to Heterogeneous Drug Distribution: Calcium Pharmacokinetics , 1996, Pharmaceutical Research.

[17]  Hans Lennernäs,et al.  EXPERIMENTAL ESTIMATION OF THE EFFECTIVE UNSTIRRED WATER LAYER THICKNESS IN THE HUMAN JEJUNUM, AND ITS IMPORTANCE IN ORAL-DRUG ABSORPTION , 1995 .

[18]  Bradley S. Turner,et al.  Viscous fingering of HCI through gastric mucin , 1992, Nature.

[19]  I. Wilding,et al.  Scintigraphic and pharmacokinetic assessment of a multiparticulate sustained release formulation of diltiazem , 1991 .

[20]  W. Hauck,et al.  Absorption Rate Vs. Exposure: Which Is More Useful for Bioequivalence Testing? , 1996, Pharmaceutical Research.

[21]  Michael F. Shlesinger,et al.  Time‐Scale Invariance in Transport and Relaxation , 1991 .

[22]  J. Bassingthwaighte,et al.  Fractal Nature of Regional Myocardial Blood Flow Heterogeneity , 1989, Circulation research.

[23]  J. Dressman,et al.  Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.

[24]  Raoul Kopelman,et al.  Fractal Reaction Kinetics , 1988, Science.

[25]  T. Macgregor,et al.  The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man , 1974, Journal of Pharmacokinetics and Biopharmaceutics.

[26]  W. Cannon,et al.  The mechanical factors of digestion , 1911 .

[27]  L. Holm,et al.  Microscopy of acid transport at the gastric surface in vivo , 1990, Journal of internal medicine. Supplement.

[28]  Lawrence X. Yu,et al.  Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .

[29]  Gérard Daccord Chemical dissolution of a porous medium by a reactive fluid. , 1987 .

[30]  B. Krevsky,et al.  Colonic transit scintigraphy. A physiologic approach to the quantitative measurement of colonic transit in humans. , 1986, Gastroenterology.

[31]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[32]  Davide Verotta,et al.  Two constrained deconvolution methods using spline functions , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[33]  M. Spino,et al.  High Variability in Drug Pharmacokinetics Complicates Determination of Bioequivalence: Experience with Verapamil , 1996, Pharmaceutical Research.

[34]  Patrick J. Sinko,et al.  Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach , 1991, Pharmaceutical Research.

[35]  G. Daccord,et al.  Fractal patterns from chemical dissolution , 1987, Nature.

[36]  L. C. Feely,et al.  Gastrointestinal transit of non-disintegrating tablets in fed subjects , 1989 .

[37]  R. Spiller,et al.  Emptying of the terminal ileum in intact humans: Influence of meal residue and ileal motility , 1987 .

[38]  Bruce J. West,et al.  Fractal physiology , 1994, IEEE Engineering in Medicine and Biology Magazine.